查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1611288

稀有生物标记检体采集和稳定市场：按产品类型、采集类型、应用和最终用途 - 2025-2030 年全球预测

Rare Biomarkers Specimen Collection & Stabilization Market by Product Type, Collection Type, Application, End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

稀有生物标记检体收集和稳定市场2023年估值为299.4亿美元，预计到2024年将达到322.1亿美元，复合年增长率为7.54%，到2030年预计将达到498.3亿美元。

稀有生物标记检体采集和稳定市场涵盖专门的医疗保健领域，专注于收集、保存和分析极少量的独特生物标记。这些生物标记对于早期疾病诊断、个人化医疗和长期健康监测至关重要。这项市场需求源自于对精准医疗日益增长的需求，这需要能够维持从源头到分析的生物完整性的敏感技术。应用范围涵盖肿瘤学、产前检测、神经病学和感染疾病诊断，最终用户包括临床实验室、研究和学术机构以及生物製药公司。诊断技术的进步、生物标记研究资金的增加以及慢性病盛行率的上升推动了市场成长。例如，政府支持个人化医疗的倡议将显着提升市场潜力。市场扩张机会包括开发自动化和数位解决方案，以简化检体采集和稳定工作流程。然而，挑战依然存在，包括严格的法律规范、高昂的营运成本以及管理检体随时间劣化的技术限制。另一个限制因素是缺乏熟悉尖端生物标记技术的熟练专业人员。创新技术包括开发便携式、易于使用的收集设备和新的稳定方法，这些方法可以延长检体的保质期，而无需严重依赖低温运输物流。市场本质上是竞争激烈且分散的，既有老字型大小企业，也有新兴企业。技术进步和监管环境的动态本质既带来了机会，也带来了威胁。投资于合作努力，例如与学术研究机构合作进行早期创新，是获得优势的一项有前景的策略。公司应专注于适应性技术，进行严格的市场情报以预测市场状况的变化，定位自己以回应新的需求，并利用已发现的差距。

主要市场统计
基准年[2023] 299.4亿美元
预计年份 [2024] 322.1亿美元
预测年份 [2030] 498.3亿美元
复合年增长率（%） 7.54%

市场动态：针对快速发展的稀有生物标记检体采集和稳定市场揭示的关键市场见解

供需的动态交互作用正在改变稀有生物标记检体采集和稳定市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 人们越来越偏好非侵入性疾病治疗
    • 个人化医疗需求不断成长
    • 越来越多的研究阐明循环生物标记的作用
  • 市场限制因素
    • 行业监管严格
  • 市场机会
    • 液态切片活检等新检测方法的创新
    • 联合市场开拓倡议
  • 市场挑战
    • 有限兑换场景
    • 表征复杂性和低效的分离通讯协定

波特的五力：驾驭稀有生物标记检体采集和稳定市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解稀有生物标记检体采集和稳定市场的外部影响

外部宏观环境因素在塑造稀有生物标记检体收集和稳定市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解稀有生物标记检体采集和稳定市场的竞争状况

稀有生物标记物检体采集和稳定市场的详细市场占有率分析提供了对供应商绩效的全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵评估供应商在稀有生物标记检体收集和稳定市场的表现

FPNV 定位矩阵是评估稀有生物标记检体收集和稳定市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製稀有生物标记检体采集和稳定市场的成功之路

对于希望加强其在全球市场的影响力的公司来说，稀有生物标记检体采集和稳定市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 非侵入性疾病治疗越来越受欢迎
      • 对个人化医疗的需求不断增长
      • 越来越多的研究描述了循环生物标记的作用
    • 抑制因素
      • 严格的行业法规
    • 机会
      • 新的检测创新，例如液态生物检体检测
      • 市场开发联合倡议
    • 任务
      • 有限兑换场景
      • 表征复杂性和低效的分离通讯协定
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章稀有生物标记检体采集与稳定市场：依产品类型

  • 循环细胞游离DNA
  • 循环性肿瘤细胞
  • 胞外体或细胞外囊泡

第七章稀有生物标记检体采集与稳定市场（依采集类型）

  • 采血管及采血管系统
  • 分离试剂套件和试剂

第八章稀有生物标记检体采集与稳定市场：依应用分类

  • 心血管疾病
  • NIPT
  • 肿瘤学
  • 药物基因组学
  • 人群筛检
  • 转录组学
  • 移植排斥反应

第九章稀有生物标记检体采集与稳定市场：依最终用途分类

  • 医院
  • 周产期门诊
  • 医生实验室
  • 私人或商业实验室
  • 公共卫生研究所
  • 调查机构

第十章美洲稀有生物标记检体采集与稳定市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区稀有生物标记检体采集及稳定市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的稀有生物标记检体采集和稳定市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • ABL, Inc.
  • ACM Global Laboratories
  • Almac Group
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • BioAgilytix Labs, LLC
  • bioMerieux, Inc.
  • Charles River Laboratories International, Inc.
  • IQVIA Inc.
  • Labcorp Drug Development
  • NorthEast BioAnalytical Laboratories LLC
  • PerkinElmer Inc.
  • SGS Societe Generale de Surveillance SA
  • Svar Life Science AB
  • Synexa Life Sciences BV
Product Code: MRR-B812DD579A1C

The Rare Biomarkers Specimen Collection & Stabilization Market was valued at USD 29.94 billion in 2023, expected to reach USD 32.21 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 49.83 billion by 2030.

The rare biomarkers specimen collection and stabilization market encompasses a specialized healthcare sector focused on collecting, preserving, and analyzing distinct biological markers that are present in minuscule quantities. These biomarkers are critical for early disease diagnosis, personalized medicine, and longitudinal health monitoring. The necessity of this market arises from the increasing demand for precision medicine, necessitating highly sensitive technologies capable of preserving biological integrity from source to analysis. Applications span oncology, prenatal testing, neurology, and infectious disease diagnostics, with end-users including clinical laboratories, research and academic institutions, and biopharmaceutical companies. Market growth is driven by advances in diagnostic technologies, increased funding for biomarker research, and the rising prevalence of chronic diseases. For instance, government initiatives supporting personalized medicine boost market potential significantly. Opportunities for expansion include developing automation and digital solutions that streamline specimen collection and stabilization workflows. However, challenges persist, including stringent regulatory frameworks, high operational costs, and technological limitations in managing specimen degradation over time. Another limiting factor is the shortage of skilled professionals adept in cutting-edge biomarker technologies. Innovations could include developing portable and user-friendly collection devices and novel stabilization methods that extend the shelf-life of specimens without heavy reliance on cold-chain logistics. The market is inherently competitive and fragmented, characterized by the presence of well-established companies and startups alike. The dynamic nature of technological advancements and regulatory landscapes can be both an opportunity and a threat. Investing in collaborative endeavors, such as partnerships with academic and research institutions for early-stage innovations, presents a promising strategy to stay ahead. Businesses are advised to focus on adaptive technologies and conduct rigorous market intelligence to anticipate shifts in the market landscape, ensuring they are poised to address emerging needs and capitalizing on identified gaps.

KEY MARKET STATISTICS
Base Year [2023] USD 29.94 billion
Estimated Year [2024] USD 32.21 billion
Forecast Year [2030] USD 49.83 billion
CAGR (%) 7.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Rare Biomarkers Specimen Collection & Stabilization Market

The Rare Biomarkers Specimen Collection & Stabilization Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising preference of a non-invasive mode of disease treatment
    • Increasing demand for personalized medicine
    • Growth in number of research studies to depict the role of circulating biomarkers
  • Market Restraints
    • Stringent regulations in the industry
  • Market Opportunities
    • Innovation of novel assays such as liquid biopsy assays
    • Collaborative initiatives for market developments
  • Market Challenges
    • Limited reimbursement scenario
    • Complexities in characterization and ineffective separation protocols

Porter's Five Forces: A Strategic Tool for Navigating the Rare Biomarkers Specimen Collection & Stabilization Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Rare Biomarkers Specimen Collection & Stabilization Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Rare Biomarkers Specimen Collection & Stabilization Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Rare Biomarkers Specimen Collection & Stabilization Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Rare Biomarkers Specimen Collection & Stabilization Market

A detailed market share analysis in the Rare Biomarkers Specimen Collection & Stabilization Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Rare Biomarkers Specimen Collection & Stabilization Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Rare Biomarkers Specimen Collection & Stabilization Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Rare Biomarkers Specimen Collection & Stabilization Market

A strategic analysis of the Rare Biomarkers Specimen Collection & Stabilization Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Rare Biomarkers Specimen Collection & Stabilization Market, highlighting leading vendors and their innovative profiles. These include ABL, Inc., ACM Global Laboratories, Almac Group, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., BioAgilytix Labs, LLC, bioMerieux, Inc., Charles River Laboratories International, Inc., IQVIA Inc., Labcorp Drug Development, NorthEast BioAnalytical Laboratories LLC, PerkinElmer Inc., SGS Societe Generale de Surveillance SA, Svar Life Science AB, and Synexa Life Sciences BV.

Market Segmentation & Coverage

This research report categorizes the Rare Biomarkers Specimen Collection & Stabilization Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Circulating Cell Free DNA, Circulating Tumor Cells, and Exosomes or Extracellular Vesicles.
  • Based on Collection Type, market is studied across Blood Collection Tubes & Systems and Isolation Kits & Reagents.
  • Based on Application, market is studied across Cardiovascular Diseases, NIPT, Oncology, Pharmacogenomics, Population Screening, Transcriptomics, and Transplant Rejection.
  • Based on End Use, market is studied across Hospitals, Perinatal Clinics, Physician Labs, Private or Commercial Labs, Public Health Labs, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising preference of a non-invasive mode of disease treatment
      • 5.1.1.2. Increasing demand for personalized medicine
      • 5.1.1.3. Growth in number of research studies to depict the role of circulating biomarkers
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations in the industry
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovation of novel assays such as liquid biopsy assays
      • 5.1.3.2. Collaborative initiatives for market developments
    • 5.1.4. Challenges
      • 5.1.4.1. Limited reimbursement scenario
      • 5.1.4.2. Complexities in characterization and ineffective separation protocols
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Rare Biomarkers Specimen Collection & Stabilization Market, by Product Type

  • 6.1. Introduction
  • 6.2. Circulating Cell Free DNA
  • 6.3. Circulating Tumor Cells
  • 6.4. Exosomes or Extracellular Vesicles

7. Rare Biomarkers Specimen Collection & Stabilization Market, by Collection Type

  • 7.1. Introduction
  • 7.2. Blood Collection Tubes & Systems
  • 7.3. Isolation Kits & Reagents

8. Rare Biomarkers Specimen Collection & Stabilization Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Diseases
  • 8.3. NIPT
  • 8.4. Oncology
  • 8.5. Pharmacogenomics
  • 8.6. Population Screening
  • 8.7. Transcriptomics
  • 8.8. Transplant Rejection

9. Rare Biomarkers Specimen Collection & Stabilization Market, by End Use

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Perinatal Clinics
  • 9.4. Physician Labs
  • 9.5. Private or Commercial Labs
  • 9.6. Public Health Labs
  • 9.7. Research Institutes

10. Americas Rare Biomarkers Specimen Collection & Stabilization Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Rare Biomarkers Specimen Collection & Stabilization Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Rare Biomarkers Specimen Collection & Stabilization Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. ABL, Inc.
  • 2. ACM Global Laboratories
  • 3. Almac Group
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. BioAgilytix Labs, LLC
  • 7. bioMerieux, Inc.
  • 8. Charles River Laboratories International, Inc.
  • 9. IQVIA Inc.
  • 10. Labcorp Drug Development
  • 11. NorthEast BioAnalytical Laboratories LLC
  • 12. PerkinElmer Inc.
  • 13. SGS Societe Generale de Surveillance SA
  • 14. Svar Life Science AB
  • 15. Synexa Life Sciences BV

LIST OF FIGURES

  • FIGURE 1. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET RESEARCH PROCESS
  • FIGURE 2. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET DYNAMICS
  • TABLE 7. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CIRCULATING CELL FREE DNA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CIRCULATING TUMOR CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY EXOSOMES OR EXTRACELLULAR VESICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY BLOOD COLLECTION TUBES & SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ISOLATION KITS & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY NIPT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY POPULATION SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY TRANSPLANT REJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PERINATAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PHYSICIAN LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRIVATE OR COMMERCIAL LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PUBLIC HEALTH LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY COLLECTION TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 197. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. RARE BIOMARKERS SPECIMEN COLLECTION & STABILIZATION MARKET, FPNV POSITIONING MATRIX, 2023